Increased prescribing of psychotropic medication for children and adolescents during the COVID‐19 pandemic: no cause for alarm
- 23 May 2023
- journal article
- editorial
- Published by Wiley in The Medical Journal of Australia
- Vol. 219 (1), 16-17
- https://doi.org/10.5694/mja2.51977
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inequalities in Access to Mental Health Treatment by Australian Youths During the COVID-19 PandemicPsychiatric Services, 2023
- Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID‐19 pandemic, 2013–2021: a retrospective cohort studyThe Medical Journal of Australia, 2023
- Psychotropic medication prescribing for children and adolescents by general practitioners during the COVID‐19 pandemicThe Medical Journal of Australia, 2023
- Psychotropic consumption before and during COVID-19 in Asturias, SpainBMC Public Health, 2023
- Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young AdultsJAMA Psychiatry, 2023
- Psychotropic medication use in pediatric population during COVID‐19 pandemicActa Psychiatrica Scandinavica, 2022
- The impact of the COVID-19 pandemic on paediatric health service use within one year after the first pandemic outbreak in New South Wales Australia – a time series analysisThe Lancet Regional Health - Western Pacific, 2021
- The impact of COVID-19 on the lives and mental health of Australian adolescentsEuropean Child & Adolescent Psychiatry, 2021
- Impact of the Canterbury earthquakes on dispensing of psychiatric medication for children and adolescents: longitudinal quantitative studyThe British Journal of Psychiatry, 2020